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Purpose Background 
There is still debate on whether steroids withdrawal is the best option in the immunosuppression of 
heart transplant patients. While we know the frequency of this practice in Spain, little is known on 
the magnitude of the potential beneficial effect in different clinical variables (i.e. renal function) 
really achieved for the extra rejection risk assumed associated with steroids withdrawal. Aim: To 
study the association between steroids withdrawal during the first year after heart transplantation 
(HT) and changes in renal function during the following two years. 
 
Methods 
Historical cohort study done in 13 Spanish HT centers. 908 HT patients older than 18 years 
(81.9% males and with a mean age of 52 years (standard deviation=11)). All HT were done 
between 2000 and 2005 and only patients with complete information both on steroids treatment 
one year after HT and on renal function one and three years after HT were considered in this 
analysis. The glomerular filtration rate was estimated (eGFR) by the MDRD formula and its 
changes between first and third year after HT where analyzed in three different groups depending 
on steroids treatment one year after HT: A) No steroids; B) Low doses (≤ 5mg/día) y C) High 
doses (> 5mg/día), and these changes compared among groups. Severe renal dysfunction was 
considered when eGFR< 30 mL/min/1.73m2. 
 
Results 
At the one-year visit, 99 (10.9%) patients were without steroids (Group A), 271 (29.9%) with low 
doses (B) and 538 (59.2%) with high doses (C). At this point in time, the three groups showed 
very similar eGFR (mean [standard deviation] in A=61 [23.1], B=62.4 [22.9] y C=60.7 [19.7]). 
The no-steroids group (A) improved its eGFR from year one to year three (mean increase 6.9 
[95% C.I.= 3.4-10.3] while in the two other groups it did not change (difference 0.4 [95% C.I.= -
1.5-2.3] and -0.9 [95% C.I.= -2.6-0.8] in B and C respectively). Correspondingly, prevalence of 
severe renal dysfunction decreased from 7.1% to 2% in group A, a difference not statistically 
significant, though. 
  
Conclusion 
Steroids withdrawal is associated with an improve in renal function thereafter that, although of 
modest magnitude, might be of potential clinical relevance due to the high prevalence of renal 
dysfunction among HT patients. 
 
 
